6505NCM206710: CORONAVIRUS VACCINE.
The CORONAVIRUS VACCINE is a the manufacturer industrial component. Key specifications include virus_strain: COVID-19, administration: INJECTION, primary_container_type: VIAL, GLASS, primary_container_content_quantity: 5.0 MILLILITERS, part_name_assigned_by_controlling_agency: ADULT MODERNA COVID-19 VACCINE, VIAL 1S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-692-5286, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| virus_strain | COVID-19 |
| administration | INJECTION |
| primary_container_type | VIAL, GLASS |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 5.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | ADULT MODERNA COVID-19 VACCINE, VIAL 1S |
| NSN | 6505-01-692-5286 |
| ADMINISTRATION | INJECTION |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.0 MILLILITERS |
| VIRUS STRAIN | COVID-19 |
| PRIMARY CONTAINER TYPE | VIAL, GLASS |
| SPECIAL FEATURES | SUSPENSION FOR INTRAMUSCULAR INJECTION; 1 MULTIPLE-DOSE VIAL OF 5 ML, EACH VIAL CONTAINS 10 TO 11 DOSES (0.5 ML EACH); EACH 0.5 ML DOSE OF THE MODERNA COVIID-19 VACCINE CONTAINS 100 MCG OF A NUCLEOSIDE-MODIFIED MESSENGER RNA ENCODING THE VIRAL SPIKE (S) GLYCOPROTEIN OF SARS-COV-2. EACH DOSE OF THE MODERNA COVID-19 VACCINE ALSO INCLUDES THE FOLLOWING INGREDIENTS: LIPIDS (SM-102; 1,2-DDIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL-2000 (PEG2000-DMG); CHOLESTEROL; AND 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE (DSPC), TROMETHAMINE, TROMETHAMINE HYDROCHLORIDE, ACETIC ACID, SODIUM ACETATE, AND SUCROSE. STORE FROZEN/BETWEEN -50 TO -15 DEGREES C (-58 TO 5 DEGREES F) UNTIL READY FOR USE; PROTECT FROM LIGHT; NO PRESERVATIVES; AFTER FIRST USE, HOLD AT 2 TO 25 DEGREES C (36 TO 77 DEGREES F), DISCARD AFTER 12 HOURS; DO NOT REFREEZE ONCE THAWED; FOR USE UNDER EMERGENCY USE AUTHORIZATION. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADULT MODERNA COVID-19 VACCINE, VIAL 1S |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |